An overview of complications associated with deferoxamine therapy in thalassemia

• Główni autorzy: Bijan Keikhaei (Autor), Neda Farmani-Anooshe (Autor), Mohammad Bahadoram (Autor), Mohammad-Reza Mahm (Autor), Kosar Alikhani (Autor), Ammar Helalinasab (Autor)
• Format: Książka
• Wydane: Society of Diabetic Nephropathy Prevention, 2021-01-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Thalassemic syndromes are the most common genetic diseases in the world that are related to blood transfusion and iron overload in the body. In ß-thalassemia major multiple blood transfusions due to ineffective erythropoiesis lead to iron excess in the body. Iron chelating agent deferoxamine is used...